Huanfen Zhao

Huanfen Zhao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in Medicine
Verified
Journal Article
Open access
YLYang Liu
Yang Liu
LKLin Kang
Lin Kang
HHHan Hao
Han Hao
XZXiuzhi Zhang
Xiuzhi Zhang
GZGuona Zheng
Guona Zheng
HZHuanfen Zhao
Huanfen Zhao
Rationale: Double primary lung cancer (DPLC) is a relatively rare type of lung cancers. According to whether the diagnosis interval between lesions is more than 6 months, it can be divided into synchronous DPLC (sDPLC) and metachronous DPLC (mDPLC). Here, we describe a case of sDPLC in which one of the components is a rare colloid adenocarcinoma (CA). Patient concerns: A 69-year-old male was admitted to the hospital due to chest distress and shortness of breath for 1 year, getting worse in the last 15 days. Diagnosis: Both HE staining and IHC supported the diagnosis of CA in the right lower lobe and moderately differentiated squamous cell carcinoma in the right upper lobe. Interventions: The patient was treated with 3 cycles of adjuvant chemotherapy with pemetrexed and lobaplatin after the right upper lobectomy, wedge resection of the right lower lobe and lymph node dissection under video-assisted thoracoscope. Outcomes: Our plan was to follow him up with general physical examination, chest-abdomen CT and serum tumor markers every 6 months for 2 years. The patient was still alive until the last follow-up in November 2020. Lessons: CA of the lung is a rare primary lung adenocarcinoma. The diagnosis should be based on the patient's clinical characteristics, imaging examination and pathological characteristics, and also need to be differentiated from other mucinous adenocarcinomas. Interestingly, our patient developed not only a CA in the right lower lobe, but also a moderately differentiated squamous cell carcinoma in the right upper lobe.

6 July 2023 in Asian Journal of Surgery
Verified
Journal Article
Open access
QMQiaoyun Min
Qiaoyun Min
YSYabin Shi
Yabin Shi
TWTongtong Wang
Tongtong Wang
HZHuanfen Zhao
Huanfen Zhao

19 July 2023 in Asian Journal of Surgery
Verified
Journal Article
Open access
XZXiangnan Zhang
Xiangnan Zhang
FYFan Yang
Fan Yang
XMXiaoli Ma
Xiaoli Ma
HZHuanfen Zhao
Huanfen Zhao

20 February 2024
Verified
Journal Article
Open access
TWTongtong Wang
Tongtong Wang
XCXiaoyue Chen
Xiaoyue Chen
GDGuochen Duan
Guochen Duan
XZXiaopeng Zhang
Xiaopeng Zhang
QZQingtao Zhao
Qingtao Zhao
HZHuanfen Zhao
Huanfen Zhao
血管内大B细胞淋巴瘤(intravascular large B-cell lymphoma, IVLBCL)是一种侵袭性结外大B细胞淋巴瘤,在同一器官与其他恶性肿瘤同时发生非常罕见,尤其是肺。本文报道1例肺腺癌合并IVLBCL的罕见病例。患者因腹泻伴发热、咳嗽入院。胸部计算机断层扫描(computed tomography, CT)示右肺上叶不规则斑片状高密度影,边缘有磨玻璃影。入院后给予患者抗感染等治疗,但仍有间断低热(最高37.5 oC)。经皮肺穿刺活检(percutaneous lung biopsy, PLB)病理诊断为贴壁生长为主的腺癌,局部考虑浸润。手术后病理诊断为肺浸润性非黏液性腺癌合并IVLBCL。本文通过分析其临床病理特征,并复习相关文献,以提高临床和病理医师对该肿瘤的认识,避免漏诊或误诊。

30 August 2024 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
FLFang Luyao
Fang Luyao
ZXZhang Xiangnan
Zhang Xiangnan
MQMin Qiaoyun
Min Qiaoyun
ZHZhang Hui
Zhang Hui
MHMeng Huanping
Meng Huanping
HZHuanfen Zhao
Huanfen Zhao
Lymphoepithelioma-like intrahepatic cholangiocarcinoma (LEL-ICC) is a rare liver tumor that appears as a hepatic nodule on imaging with a specific pathological pattern, and the definitive diagnosis relies on its pathological histomorphology, immunophenotype, and Epstein-Barr encoding region test. Radical surgical resection is the primary treatment modality, and immunotherapy is expected to be a new adjuvant treatment option. LEL-ICC with massive multinucleated giant cell infiltration has not been reported so far. In this article, we report a patient with LEL-ICC showing massive multinucleated giant cell infiltration, review the relevant literature, and analyze its clinicopathological features and prognosis to accumulate experience for the accurate diagnosis of LEL-ICC.

26 December 2023 in World Journal of Clinical Cases
Verified
Journal Article
Open access
TWTong-Tong Wang
Tong-Tong Wang
XCXiao-Yue Chen
Xiao-Yue Chen
QMQiao-Yun Min
Qiao-Yun Min
YHYi-Ze Han
Yi-Ze Han
HZHuanfen Zhao
Huanfen Zhao
Clear cell renal cell carcinoma (ccRCC) is a common type of tumor that can metastasize to any organs and sites. However, it is extremely rare for ccRCC to metastasize to the iris. Here, we describe a rare case of iris metastasis from ccRCC with a history of left nephrectomy in 2010. A 62-year-old male was admitted to the hospital due to blurred vision and red eyes, and a mass was found on the iris in the right eye. B-scan ultrasonography revealed a well-bounded high-density lesion at the corner of the anterior chamber at the 3-4 o’clock position. Phacoemulsification with simultaneous intraocular lens implantation and iridocyclectomy was performed in the right eye. The lesion was confirmed to be metastatic ccRCC by histological and immunohistochemical analyses. The patient was still alive at 9 mo after surgical treatment. Ocular metastasis can be an initial sign with a poor prognosis. Timely detection and treatment may improve survival. Clinicians should pay attention to similar metastatic diseases to prevent misdiagnosis leading to missed treatment oppor tunities. This report of the characteristics and successful management of a rare case of iris metastasis from ccRCC highlights the importance of a comprehensive medical history, histopathology, immunohistochemistry, and clinical manifestation for successful disease diagnosis.